Clinical Trials Browser

Unknown × Neuroendocrine Tumors × Nivolumab × Clear all

NCT04525638 2022-08-02

A Clinical Study to Assess the Combination of Two Drugs (177Lu-DOTATATE and Nivolumab) in Neuroendocrine Tumours

Phase 2 Unknown

Carcinoma, Neuroendocrine, Neuroendocrine Tumors